T cell-engaging bispecific antibodies for myeloid malignancies: Targets, formats, and clinical challenges
Summary: T cell-engaging bispecific antibodies (T-BsAbs) have revolutionized immunotherapy for hematologic malignancies, showing promise in lymphoid cancers and myeloma. However, their application in myeloid malignancies like acute myeloid leukemia (AML) faces challenges due to myelotoxicity and lim...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2026-05-01
|
| Edice: | Cell Reports Medicine |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2666379126001898 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|